MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹4,446 Cr | ₹2,461 Cr | ₹1,780 Cr | ₹2,526 Cr | ₹1,569 Cr |
What is the latest Net Current Assets ratio of MANKIND PHARMA ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹4,446 Cr |
Mar2023 | ₹2,461 Cr |
Mar2022 | ₹1,780 Cr |
Mar2021 | ₹2,526 Cr |
Mar2020 | ₹1,569 Cr |
How is Net Current Assets of MANKIND PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹4,446 Cr | 80.62 | |
Mar2023 | ₹2,461 Cr | 38.25 | |
Mar2022 | ₹1,780 Cr | -29.52 | |
Mar2021 | ₹2,526 Cr | 61.03 | |
Mar2020 | ₹1,569 Cr | - |
Compare Net Current Assets of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹105,592.6 Cr | -0.6% | 7.9% | 6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.6% |
7.9% |
6.6% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses